Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)

Go back to Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)
AbbVie (NYSE: ABBV) Delayed: 259.36 +2.44 (0.95%)
Previous Close $256.92    52 Week High $68.12 
Open $258.54    52 Week Low $50.71 
Day High $260.22    P/E 56.26 
Day Low $256.77    EPS $4.61 
Volume 4,195,205       

Gilead Sciences (NASDAQ: GILD) Delayed: 129.31 -1.55 (1.18%)
Previous Close $130.86    52 Week High $108.63 
Open $130.93    52 Week Low $71.39 
Day High $131.65    P/E 71.44 
Day Low $129.04    EPS $1.81 
Volume 5,529,733       

Merck & Co. (NYSE: MRK) Delayed: 131.07 +0.59 (0.45%)
Previous Close $130.48    52 Week High $65.46 
Open $131.44    52 Week Low $47.97 
Day High $131.71    P/E 89.16 
Day Low $130.24    EPS $1.47 
Volume 6,154,306       

REGULUS THERAP (NASDAQ: RGLS) Delayed: 8.16 --0 (-0%)
Previous Close $8.16    52 Week High $10.60 
Open $8.16    52 Week Low $2.13 
Day High $8.16    P/E 0.21 
Day Low $8.16    EPS $38.45 
Volume 14